Events at a glance
- Cambridge Public Health
- Learn to Discover (L2D)
- Accelerating Therapeutic Designing with Novel Approaches- Cambridge New Therapeutics Forum (CamNTF) event
- Cambridge Ignite 2025
- Milner Therapeutics Symposium
- Practical Application of Toxicology in Drug Development 2025
Cambridge Public Health Grants Writing Workshop on ECRs and MCRs
What to expect
- A short, informal talk from a member of the RSS Specialist Centre for Public Health, with plenty of opportunities for questions.
- An interactive discussion, using past applications to explore what makes a proposal successful, common pitfalls, and how to avoid them.
- A networking lunch.
- Optional one-to-one advice sessions after lunch: Attendees can register for a 15-minute session with an RSS team member to discuss their current fellowship or funding application.
Register: Book your place at the workshop here.
Learn to Discover (L2D)
Learn to Discover (L2D) is a cutting edge online training course in Python programming, data science and machine learning, tailored for health, disease and bioscience. L2D is accredited for CPD purposes by the Royal College of Physicians and the Royal Society of Biology.
The next course will start on Monday 12th May 2025. Please find the course schedule attached.
To register your interest, please complete the online form here.
More information, student testimonials and information video can be found on their website: https://learntodiscover.ai.
Accelerating Therapeutic Designing with Novel Approaches- Cambridge New Therapeutics Forum (CamNTF) event
Join us for an exciting evening of cutting-edge science and networking!
Hosted by the Cambridge Academy of Therapeutic Sciences (CATS), University of Cambridge, the next Cambridge New Therapeutics Forum (CamNTF) brings together leading experts from academia and industry to explore innovations in therapeutic design.
Accelerating Therapeutics Designing with Novel Approaches
Featured Speakers:
Pietro Sormanni, Royal Society University Research Fellow, University of Cambridge
Third generation approaches of antibody discovery and engineering
Iain Moal, Scientific Leader, GlaxoSmithKline
Designing High-Potency Antibodies using Machine Learning and Next-Generation Sequencing
Bill Eldridge, VP of Biologics, Constructive Bio
New to Nature: Rewriting Life’s Code to Expand the Protein Universe
The evening will conclude with networking and refreshments.
Attendance is free, but registration is essential. Spaces are limited so please register early to secure your spot!
Register here: https://www.eventbrite.co.uk/e/cambridge-new-therapeutics-forum-camntf-event-tickets-862933636737?aff=oddtdtcreator
Cambridge Ignite 2025
Ignite is a one-week international entrepreneurial training programme for researchers and entrepreneurs looking to commercialise their innovation. Comprised of a blend of practical teaching sessions delivered by the world's leading faculty and practitioners, tailored coaching sessions, and clinics with industry experts and entrepreneurs, it provides delegates with the knowledge, tools, contacts and confidence to transform their ideas into successful business projects.
Fee: UoC affiliated fee - £1,300, Standard fee - £2,100, Corporate fee - £3,000
Funding is available for postdocs and early career researchers from the University of Cambridge who are working on an idea related to the area of Medtech, therapeutics and medical devices
Milner Therapeutics Symposium
- Ijeoma Uchegbu, Wolfson College, University of Cambridge
- Sam Barrell, LifeArc
- Shankar Balasubramanian, Yusuf Hamied Department of Chemistry, University of Cambridge
- Jim Glasheen, Cambridge Enterprise
- Mina Ryten, UK Dementia Research Institute
- Simon Lovestone, Johnson & Johnson
Free to academic researchers and Milner affiliates, Consortium companies and venture partners, the Symposium provides excellent opportunities to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. 500 delegates will be welcomed at the West Road Concert Hall in Cambridge, and talks will also be live-streamed for their international delegates.
Practical Application of Toxicology in Drug Development 2025
The highly acclaimed Practical Application of Toxicology in Drug Development (PATDD) course co-organised by Cambridge Academy of Therapeutic Sciences (CATS) and The British Toxicology Society (BTS) provides comprehensive training in toxicology as applied to drug development, catering to scientists from around the globe. Participants will gain a thorough understanding of non-clinical safety evaluation principles, with a strong focus on practical applications and interpreting safety data. Both European and US regulatory toxicology perspectives will be covered.
Registrations are now open!
Please check CATS website for more information regarding the course.
Any questions about this course, please contact cats@admin.cam.ac.uk
